ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 737613 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 737613; 2) Community: the network communities that were significantly associated with the response to NSC 737613; 3) Molecule: the relationships between components within communities and NSC 737613; 4) MDR: the compounds that were significantly associated with the NSC 737613.

NSC Compound Enrichment Correlation
NSC 682768 Null 0.00457614317494024 -0.36719931
NSC 703105 Null 0.00457614317494024 0.4209777
NSC 707904 Null 0.00457614317494024 0.29535469
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.00457614317494024 0.21965628
NSC 726267 Null 0.00457614317494024 -0.17798102
NSC 736041 7-(5-diethylaminopentyloxy)-5-hydroxy-2-phenyl-4H-4-chromeno ne 0.00457614317494024 0.41633935
NSC 740476 Null 0.00457614317494024 0.43916173
NSC 79093 5-Hydroxy-6,7,8,4'-tetramethoxyflavone 0.00457614317494024 0.12781026
NSC 102817 Germacra-1(10),11(13)-diene-12,14-dioic acid, 4,5.alpha.-epoxy-2.beta.,6.alpha.,8.alpha.-trihydroxy-, 12,6:14,2-dilactone, 3-methylcrotonate (8CI) 0.00479683626511385 0.41954286
NSC 113951 6-Bromotoyocamycin 0.00479683626511385 0.35883557
Total:110  Current:19    [First] [Prev] [Next] [Last]